Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Wayland Group Corp MRRCF

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic Cannabis
Wayland Group Corp, formerly Maricann Group Inc produces and sells medical marijuana. It is currently engaged in cultivation, extraction, analytics and production facilities to elevate offerings and prepare for growth into the adult-use cannabis market in Canada.


GREY:MRRCF - Post by User

Wayland Group Corp
Bullboard Posts
User Avatar Image
(0)
•••
Comment by truestar2on Sep 11, 2017 6:35pm
63 Views
Post# 26682257

RE:RE:RE:RE:Undervalued due to misunderstanding - good buy op

RE:RE:RE:RE:Undervalued due to misunderstanding - good buy opI don't know anything about his previous company.  I do know his new COO James Hyssen really well and I know between the two of them they will be very credible in the pharmaceutical space in Europe.  Many of the moves Ben has made have been very prudent, https://www.benzinga.com/trading-ideas/long-ideas/17/06/9607082/maricann-ceo-talks-c-42-5m-financing-round-and-german-expansi
I"m certain he understands the importance of proper communication and perhaps has been so wrapped in doing deals that he needs to also learn how to communicate to the street and his shareholders better
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities